The Immunoproteasomes Regulate LPS-Induced TRIF/TRAM Signaling Pathway in Murine Macrophages

Cell Biochemistry and Biophysics

Volumn 60, Issue 1-2, 2011, Pages 119-126

  Reis, Julia ^a,b   Hassan, Ferdaus ^a   Guan, Xiu Qin ^a   Shen, Jing ^a   Monaco, John J ^c   Papasian, Christopher J ^a   Qureshi, Asaf A ^a   Van Way III, Charles W ^b   Vogel, Stefanie N ^d   Morrison, David C ^a   Qureshi, Nilofer ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Endotoxic shock; Inflammation; Macrophages; Nitric oxide

Indexed keywords

AUTACOID; CYSTEINE PROTEINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; LIPOPOLYSACCHARIDE; LMP 2 PROTEIN; LMP-2 PROTEIN; LMP7 PROTEIN; NITRIC OXIDE; PROTEASOME; PSMB10 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TICAM 1 PROTEIN, MOUSE; TICAM-1 PROTEIN, MOUSE; TICAM2 PROTEIN, HUMAN; TIRP PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; FEMALE; GENETICS; MACROPHAGE; MALE; METABOLISM; MOUSE; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; FEMALE; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, INTERLEUKIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS;

EID: 79955938711     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9183-7     Document Type: Article

References (28)

1. Qureshi, N., Perera, P.-Y., Splitter, G., Morrison, D. C., & Vogel, S. N. (2003). The Proteasome as a LPS-binding protein in macrophages. Toxic lipopolysaccharide activates the proteasome complex. Journal of Immunology, 171, 1515-1525.
2. Qureshi, N., Vogel, S. N., van Way, C., III, Papasian, C. J., Qureshi, A. A., & Morrison, D. C. (2000). The proteasome. A central regulator of Inflammation and macrophage function. Immunologic Research, 31, 243-260.
3. Shen, J., Reis, J., Morrison, D. C., Papasian, C., Sreekumar, R., Kolbert, C., et al. (2006). Key Inflammatory signaling pathways are regulated by the proteasome. Shock, 25, 472-484.
4. Shen, J., Gao, J. J., Zhang, G., Tan, X., Morrison, D. C., Papasian, C., et al. (2006). Proteasome inhibitor, lactacystin blocks CpG DNA- and peptidoglycan induced inflammatory genes, cytokines and mitogen-activated protein kinases in macrophages. Shock, 25, 594-599.
5. Hirsch, C., & Pleogh, H. L. (2000). Intracellular targeting of the proteasome. Trends in Cell Biology, 10, 268-272.
6. Lorsbach, R. B., Murphy, W. J., Lowenstein, C. J., Snyder, S. H., & Russell, S. W. (1993). Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing: Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. Journal of Biological Chemistry, 268, 1908-1913.
7. Groettrup, M., Khan, S., Schwarz, K., & Schmidtke, G. (2001). Interferon-γ inducible exchanges of 20S proteasome active subunits: Why? Biochimie, 83, 367-372.
8. Gaczynska, M., Rock, K. L., Spies, T., & Goldberg, A. L. (1994). Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Journal of Biological Chemistry, 91, 9213-9217.
9. Reis, J., Guan, X., Kisselev, A., Papasian, C. J., Qureshi, A. A., Morrison, D. C., van Way III, C. W., Vogel, S. N., & Qureshi, N. (2010). LPS-induced formation of immunoproteasomes: TNF and nitric oxide regulated by altered composition of proteasomes-active sites. Cell Biochemistry and Biophysics. doi: 10. 1007/s12013-011-9182-8.
10. Caudill, C. M., Jayapu, K., Elenich, L., Monaco, J. J., Colbert, R. A., & Griffin, T. A. (2006). T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens. Journal of Immunology, 176, 4075-4082.
11. Rechsteiner, M., Realini, C., & Ustrell, V. (2000). The proteasome activator 11S REG (PA28) and class I antigen presentation. Biochemical Journal, 345, 1-15.
12. Elenich, L. A., Nandi, D., Kent, A. E., McCuskey, T. S., Cruz, M., Lyer, M. N., et al. (1999). The complete primary structure of mouse 20S proteasomes. Immunogenetics, 49, 835-842.
13. + T cell responses. Journal of Immunology, 177, 7680-7688.
14. Hensley, S. E., Zanker, D., Dolan, B. P., David, A., Hickman, H. D., Embry, A. C., et al. (2010). Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses. Journal of Immunology, 184, 4115-4122.
15. Seifert, U., Bialy, L. P., Ebstein, F., Bech-Otschir, D., Voight, A., Schroter, F., et al. (2010). Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell, 142, 613-624.
16. Qureshi, N., Takayama, K., Mascagni, P., Honovich, J., Wong, R., & Cotter, R. J. (1988). Complete structural determination of lipopolysaccharides obtained from deep rough mutant of Escherichia coli: Purification by high performance liquid chromatography and direct analysis by plasma desorption mass spectrometry. Journal of Biological Chemistry, 263, 11971-11976.
17. Denizot, F., & Lang, R. (1986). Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods, 89, 271-277.
18. Reis, J., Xiaoyu, T., Yang, R., Rockwell, C. E., Papasian, C. J., Vogel, S. N., et al. (2008). A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model. Innate Immunity, 14, 319-329.
19. O'Neill, L. A., Bryant, J. C. E., & Doyle, S. I. (2009). Therapeutic targeting of toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacological Reviews, 61, 177-197.
20. Keating, S. E., & Bowie, A. G. (2009). Role of Non-degradative ubiquitination in interleukin and toll-like receptor signaling. Journal of Biological Chemistry, 284, 8217-8221.
21. Wertz, I. E., & Dixit, V. M. (2010). Signaling to NF-κB: Regulation by ubiquitination. Cold Spring Harbor Perspectives in Biology, 2, a003350.
22. Poltorak, A. X., Smirnova, H. I., Liu, M. Y., Huffel, C. V., Du, X., Birdwell, D., et al. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science, 282, 2085-2088.
23. Vogel, S. N., Fitzgerald, K. A., & Fenton, M. J. (2003). TLRs: Differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Molecular Interventions, 3, 466-477.
24. Tseng, P.-H., Matsuzawa, A., Zhang, W., Mino, T., Vignali, D. A. A., & Karin, M. (2010). Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nature Immunology, 11, 70-75.
25. Kutuzova, G., Albrecht, R., Erickson, C., & Qureshi, N. (2001). Diphosphoryl lipid A from Rhodobacter sphaeroides blocks the binding and internalization of toxic lipopolysaccharide in RAW 264. 7 cells. Journal of Immunology, 167, 482-489.
26. Kagan, J. C., Su, T., Horng, T., Chow, A., Akira, S., & Medzhitov, R. (2008). Tram couples endocytosis of toll-like receptor 4 to the induction of interferon-β. Nature Immunology, 9, 361-368.
27. Gao, J. J., Filla, M. B., Fultz, M. J., Vogel, S. N., Russell, S. W., & Murphy, W. J. (1998). Autocrine/paracrine IFN-αβ mediates the lipopolysaccharide-induced activation of transcription factor STAT1α in mouse macrophages: Pivotal role of STAT1α in induction of the inducible nitric oxide synthase gene. Journal of Immunology, 161, 4803-4810.
28. Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., et al. (2009). Cancer Cell, 15, 103-113.